Zobrazeno 1 - 10
of 242
pro vyhledávání: '"Scott M Berry"'
Autor:
James W Keck, Jess Lindner, Matthew Liversedge, Blazan Mijatovic, Cullen Olsson, William Strike, Anni Noble, Reuben Adatorwovor, Parker Lacy, Ted Smith, Scott M Berry
Publikováno v:
JMIR Public Health and Surveillance, Vol 9, p e44657 (2023)
BackgroundWastewater surveillance provided early indication of COVID-19 in US municipalities. Residents of long-term care facilities (LTCFs) experienced disproportionate morbidity and mortality early in the COVID-19 pandemic. We implemented LTCF buil
Externí odkaz:
https://doaj.org/article/273be825c5b44563a7d234b5236dd614
Autor:
Donald A Berry, Andrew Ip, Brett E Lewis, Scott M Berry, Nicholas S Berry, Mary MrKulic, Virginia Gadalla, Burcu Sat, Kristen Wright, Michelle Serna, Rashmi Unawane, Katerina Trpeski, Michael Koropsak, Puneet Kaur, Zachary Sica, Andrew McConnell, Urszula Bednarz, Michael Marafelias, Andre H Goy, Andrew L Pecora, Ihor S Sawczuk, Stuart L Goldberg
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0255228 (2021)
ObjectivesThe development of a prognostic mortality risk model for hospitalized COVID-19 patients may facilitate patient treatment planning, comparisons of therapeutic strategies, and public health preparations.MethodsWe retrospectively reviewed the
Externí odkaz:
https://doaj.org/article/0544c34f8de74d10831452a6e428d4c2
Autor:
Andrew Ip, Donald A Berry, Eric Hansen, Andre H Goy, Andrew L Pecora, Brittany A Sinclaire, Urszula Bednarz, Michael Marafelias, Scott M Berry, Nicholas S Berry, Shivam Mathura, Ihor S Sawczuk, Noa Biran, Ronaldo C Go, Steven Sperber, Julia A Piwoz, Bindu Balani, Cristina Cicogna, Rani Sebti, Jerry Zuckerman, Keith M Rose, Lisa Tank, Laurie G Jacobs, Jason Korcak, Sarah L Timmapuri, Joseph P Underwood, Gregory Sugalski, Carol Barsky, Daniel W Varga, Arif Asif, Joseph C Landolfi, Stuart L Goldberg
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237693 (2020)
Hydroxychloroquine has been touted as a potential COVID-19 treatment. Tocilizumab, an inhibitor of IL-6, has also been proposed as a treatment of critically ill patients. In this retrospective observational cohort study drawn from electronic health r
Externí odkaz:
https://doaj.org/article/0eb4769173b44ac7b0878cbcbb1584b3
Autor:
Jennifer L Schehr, Zachery D Schultz, Jay W Warrick, David J Guckenberger, Hannah M Pezzi, Jamie M Sperger, Erika Heninger, Anwaar Saeed, Ticiana Leal, Kara Mattox, Anne M Traynor, Toby C Campbell, Scott M Berry, David J Beebe, Joshua M Lang
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159397 (2016)
Expression of programmed-death ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC) is typically evaluated through invasive biopsies; however, recent advances in the identification of circulating tumor cells (CTCs) may be a less invasive method to
Externí odkaz:
https://doaj.org/article/8f6661b01ec84d04955efc3f9136e5d9
Autor:
Scott M Berry, Hannah M Pezzi, Eram D Williams, Jennifer M Loeb, David J Guckenberger, Alex J Lavanway, Alice A Puchalski, Cissy M Kityo, Peter N Mugyenyi, Franklin M Graziano, David J Beebe
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0143631 (2015)
Viral load (VL) measurements are critical to the proper management of HIV in developing countries. However, access to VL assays is limited by the high cost and complexity of existing assays. While there is a need for low cost VL assays, performance m
Externí odkaz:
https://doaj.org/article/e27f0af4b9674333b40c80b2912e51a7
Autor:
James W. Keck, Scott M. Berry
Publikováno v:
American journal of public health. 113(1)
Publikováno v:
Clinical Trials. 19:490-501
Background Multi-arm platform trials investigate multiple agents simultaneously, typically with staggered entry and exit of experimental treatment arms versus a shared control arm. In such settings, there is considerable debate whether to limit analy
Autor:
Andre Schultz, Julie A. Marsh, Benjamin R. Saville, Richard Norman, Peter G. Middleton, Hugh W. Greville, Matthew I. Bellgard, Scott M. Berry, Tom Snelling
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Cystic fibrosis is a genetic disease typically characterized by progressive lung damage and premature mortality. Pulmonary exacerbations, or flare-ups of the lung disease, often require hospitalization for intensive treatment. Approximately 25% of pa
Externí odkaz:
https://doaj.org/article/9a4376be32994aa3ac3fc809dad1f799
Autor:
Joshua M. Lang, Scott M. Berry, David J. Beebe, Philip J. Stephens, Scott M. Dehm, Lakeesha Carmichael, David J. Guckenberger, Benjamin K. Gibbs, Jacob Tokar, Stephanie M. Thiede, Erika Heninger, Sacha Horn, Zachery Chalmers, Benjamin P. Casavant, Allison Welsh, Lindsay N. Strotman, Jamie M. Sperger
This supplementary file contains additional Matierials and Methods detailing the VERSA process. Figure S1. Longitudinal analysis of capture efficiency of Epcam antibody. Figure S2. Multi-parametric analysis of gene expression, genomic profiling and A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ca5e0fa3cd3dead5194942679be1ba2
https://doi.org/10.1158/1078-0432.22465053
https://doi.org/10.1158/1078-0432.22465053
Autor:
Joshua M. Lang, Scott M. Berry, David J. Beebe, Philip J. Stephens, Scott M. Dehm, Lakeesha Carmichael, David J. Guckenberger, Benjamin K. Gibbs, Jacob Tokar, Stephanie M. Thiede, Erika Heninger, Sacha Horn, Zachery Chalmers, Benjamin P. Casavant, Allison Welsh, Lindsay N. Strotman, Jamie M. Sperger
Purpose: There is a critical clinical need for new predictive and pharmacodynamic biomarkers that evaluate pathway activity in patients treated with targeted therapies. A microscale platform known as VERSA (versatile exclusion-based rare sample analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e034db025c6058e5996b73db3a7aab3c
https://doi.org/10.1158/1078-0432.c.6525912
https://doi.org/10.1158/1078-0432.c.6525912